GlucoTrack announces special shareholder meeting

GlucoTrack schedules a virtual special shareholder meeting for Sept. 11, 2026.

Shareholders will be asked to vote on issuing common stock to White Lion Capital under a $50 million equity line facility, including commitment shares and warrant shares.

Approval is also being requested for common stock issuance tied to a bridge financing, covering conversion of senior secured convertible promissory notes and exercise of warrants.

The meeting may also include a vote on adjournment to allow more time to secure approval for the equity line or bridge financing items.